Paul Charpentier

Born in Paris in 1881, Paul Charpentier was a French chemist whose career unfolded in the pharmaceutical industry. He is most closely associated with work carried out at Rhône-Poulenc, where he synthesized chlorpromazine in 1950.

That compound became the first widely recognized antipsychotic drug and marked a major turning point in psychiatric treatment. Accounts of its development often place Charpentier alongside other researchers and clinicians whose combined efforts helped bring the drug into medical use.

He died in 1973. Though he was not a novelist or literary author, his name remains important in the history of medicine because of the role his chemistry played in transforming mental health care.